# CG Oncology, Inc. (CGON) CG Oncology (CGON) sees soaring social dominance and sentiment following positive bladder cancer trial data. Guggenheim initiates coverage with a 'Buy' rating and $90 target, fueling investor optimism. ### About CG Oncology, Inc. CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer. CG Oncology, Inc. uses the ticker $CGON for trading. Listed in the [Stocks](/list/stocks) category. ### Insights - CG Oncology, Inc. (CGON) social dominance is up 176% from the previous week. - CG Oncology, Inc. (CGON) Galaxy Score™ is up 61.54% from the previous week. - CG Oncology, Inc. (CGON) sentiment is up 100% from the previous week. - CG Oncology, Inc. (CGON) engagements is up 38.55% from the previous week. - CG Oncology, Inc. (CGON) mentions is up 13.01% from the previous week. - CG Oncology, Inc. (CGON) posts created is up 184.62% from the previous week. ### Price: $51.50  [Price 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/close.tsv) The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop. 24-Hour: -1.14% 7-Day: 3.71% 30-Day: -5.9% 1-Year High: $57.10 on 2026-01-21 1-Year Low: $15.60 on 2025-04-08 ### AltRank: [-----]  [AltRank 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/alt_rank.tsv) CG Oncology, Inc. (CGON) is currently AltRank #1,638 based on combined combined social and market metrics Daily Average: [---] [--] Week: [-----] +1,498 [--] Month: [-----] +682 [--] Months: [-----] +833 [--] Year: [-----] +533 1-Year High: [-----] on 2025-07-05 1-Year Low: [--] on 2025-04-28 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] +16 [--] Month: [--] [---] [--] Months: [--] [---] [--] Year: [--] [---] 1-Year High: [--] on 2025-06-02 1-Year Low: [--] on 2025-04-01 ### Engagements: [---] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/interactions.tsv) Current Value: [---] Daily Average: [------] [--] Week: [------] +39% [--] Month: [-------] -58% [--] Months: [---------] -48% [--] Year: [---------] +1.30% 1-Year High: [-------] on 2025-08-10 1-Year Low: [---] on 2026-02-15 Engagements by network (24h): TikTok: [--] Reddit: [--] X: [---] YouTube: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [---] +13% [--] Month: [---] -22% [--] Months: [-----] +26% [--] Year: [-----] +113% 1-Year High: [---] on 2026-01-10 1-Year Low: [--] on 2025-09-14 Mentions by network (24h): TikTok: [--] Reddit: [--] X: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning CG Oncology, Inc. (CGON) in the last [--] hours which is down 53% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [---] +8.80% [--] Month: [---] -25% [--] Months: [-----] -7% [--] Year: [-----] +99% 1-Year High: [---] on 2026-01-10 1-Year Low: [--] on 2025-03-05 ### Sentiment: 100%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/sentiment.tsv) Current Value: 100% Daily Average: 77% [--] Week: 100% +50% [--] Month: 100% +18% [--] Months: 100% +18% [--] Year: 100% +45% 1-Year High: 100% on 2025-02-20 1-Year Low: 6% on 2025-03-03 Most Supportive Themes: - Positive Clinical Trial Results: (70%) CG Oncology's recent positive clinical trial data for its bladder cancer therapy is a significant driver of investor confidence and positive sentiment. - Increased Social and Trading Activity: (22%) A notable surge in trading volume and social media engagement indicates growing interest and attention towards CGON. - Guggenheim Buy Rating: (8%) Guggenheim's initiation of coverage with a 'Buy' rating and a $90 price target provides a strong endorsement and potential upside for the stock. Most Critical Themes: - Analyst Downgrade: (8%) An unspecified analyst downgrade is creating negative pressure on the stock, despite the otherwise positive news. ### Social Dominance: 0.00292%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/social_dominance.tsv) Current Value: 0.00292% Daily Average: 0.011% [--] Week: 0.00276% +0.00176% [--] Month: 0.0044% -0.017% [--] Months: 0.0044% -0.0032% [--] Year: 0.0044% -0.0044% 1-Year High: 0.058% on 2026-01-11 1-Year Low: 0.0025% on 2025-09-14 ### Market Dominance: 0.00478%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_dominance.tsv) Current Value: 0.00478% Daily Average: 0% 1-Year High: 0.07% on 2025-03-31 1-Year Low: 0.00198% on 2025-04-08 ### Market Cap: $4,216,317,264  [Market Cap 24-Hour Time-Series Raw Data](/topic/$cgon/time-series/market_cap.tsv) Current Value: $4,216,317,264 Daily Average: $2,626,349,737 [--] Week: $4,216,317,264 +1.30% [--] Month: $4,255,150,678 -5.90% [--] Months: $4,255,150,678 +118% [--] Year: $4,255,150,678 +96% 1-Year High: $4,720,325,402 on 2026-01-21 1-Year Low: $1,188,220,769 on 2025-04-08 Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
CG Oncology (CGON) sees soaring social dominance and sentiment following positive bladder cancer trial data. Guggenheim initiates coverage with a 'Buy' rating and $90 target, fueling investor optimism.
CG Oncology, Inc. is a biopharmaceutical company focused on developing treatments for bladder cancer.
CG Oncology, Inc. uses the ticker $CGON for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The stock price is likely increasing due to positive clinical trial data, high sentiment, and a surge in social engagement, supported by a Guggenheim buy rating and target price of $90, despite a recent minor price drop.
24-Hour: -1.14% 7-Day: 3.71% 30-Day: -5.9%
1-Year High: $57.10 on 2026-01-21
1-Year Low: $15.60 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
CG Oncology, Inc. (CGON) is currently AltRank #1,638 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] +1,498
[--] Month: [-----] +682
[--] Months: [-----] +833
[--] Year: [-----] +533
1-Year High: [-----] on 2025-07-05
1-Year Low: [--] on 2025-04-28
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +16
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-06-02
1-Year Low: [--] on 2025-04-01
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [------] +39%
[--] Month: [-------] -58%
[--] Months: [---------] -48%
[--] Year: [---------] +1.30%
1-Year High: [-------] on 2025-08-10
1-Year Low: [---] on 2026-02-15
Engagements by network (24h): TikTok: [--] Reddit: [--] X: [---] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +13%
[--] Month: [---] -22%
[--] Months: [-----] +26%
[--] Year: [-----] +113%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): TikTok: [--] Reddit: [--] X: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning CG Oncology, Inc. (CGON) in the last [--] hours which is down 53% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +8.80%
[--] Month: [---] -25%
[--] Months: [-----] -7%
[--] Year: [-----] +99%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-03-05
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 77%
[--] Week: 100% +50%
[--] Month: 100% +18%
[--] Months: 100% +18%
[--] Year: 100% +45%
1-Year High: 100% on 2025-02-20
1-Year Low: 6% on 2025-03-03
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00292%
Daily Average: 0.011%
[--] Week: 0.00276% +0.00176%
[--] Month: 0.0044% -0.017%
[--] Months: 0.0044% -0.0032%
[--] Year: 0.0044% -0.0044%
1-Year High: 0.058% on 2026-01-11
1-Year Low: 0.0025% on 2025-09-14
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00478%
Daily Average: 0%
1-Year High: 0.07% on 2025-03-31
1-Year Low: 0.00198% on 2025-04-08
Market Cap 24-Hour Time-Series Raw Data
Current Value: $4,216,317,264
Daily Average: $2,626,349,737
[--] Week: $4,216,317,264 +1.30%
[--] Month: $4,255,150,678 -5.90%
[--] Months: $4,255,150,678 +118%
[--] Year: $4,255,150,678 +96%
1-Year High: $4,720,325,402 on 2026-01-21
1-Year Low: $1,188,220,769 on 2025-04-08
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/cg-oncology